title: Effect of L-carnitine administration on erythropoietin use in thalassemic minor haemodialysis patients.
authors.forename: Biagio R
authors.initials: BR
authors.lastname: Di Iorio
authors.forename: Pasquale
authors.initials: P
authors.lastname: Guastaferro
authors.forename: Nicola
authors.initials: N
authors.lastname: Cillo
authors.forename: Emanuele
authors.initials: E
authors.lastname: Cucciniello
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Bellizzi
mesh_terms: D002331:Carnitine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004912:Erythrocytes / Q000187:drug effects; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D006435:Renal Dialysis; D013789:Thalassemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome; D014511:Uremia / Q000150:complications / Q000628:therapy*; D014803:Vitamin B Complex / Q000627:therapeutic use*
chemical_list: D004921:Erythropoietin; D014803:Vitamin B Complex; D002331:Carnitine